Marc Lepage is returning to Canada to take the helm at Genome Quebec after spending seven years in the US. Lepage replaces interim president and CEO Denis Bilodeau, who stepped in following the departure of Jean-Marc Proulx last year. Lepage has had a long career in the public service including stints at the Medical Research Council and the Canadian Institutes of Health Research, where he served briefly as its inaugural director of business development before moving to Genome Canada where he served as executive VP corporate development for five years. He then took up a new posting as the Canadian consul general for San Francisco and San Jose where he was instrumental in strengthening S&T ties between Canada and Silicon Valley. In 2009, Lepage moved to Washington DC to work as a special advisor to the Canadian government on climate change and energy, most recently working on the Keystone Pipeline file….